# A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy Volunteers

> **NCT03420092** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 14 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Form 1 of AZD5718 tablets
- **DRUG:** Form 2 of AZD5718 tablets
- **DRUG:** Form 3 of AZD5718 tablets
- **DRUG:** Form 4 of AZD5718 tablets
- **DRUG:** Form 5 of AZD5718 tablets
- **DRUG:** Selected form (Form 2 - 5) of AZD5718 tablets

## Key facts

- **NCT ID:** NCT03420092
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-05
- **Primary completion:** 2018-04-18
- **Final completion:** 2018-04-18
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03420092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03420092, "A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03420092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*